• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BARD PERIPHERAL VASCULAR, INC. G2 FILTER SYSTEM - FEMORAL; VENA CAVA FILTER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BARD PERIPHERAL VASCULAR, INC. G2 FILTER SYSTEM - FEMORAL; VENA CAVA FILTER Back to Search Results
Catalog Number RF310F
Device Problems Malposition of Device (2616); Unintended Movement (3026); Patient Device Interaction Problem (4001)
Patient Problems Death (1802); Pain (1994); Blood Loss (2597)
Event Type  Death  
Manufacturer Narrative
Manufacturing review: a lot history review was performed.This is the only complaint to date for this lot number.Therefore, a device history record (dhr) review is not required.Investigation summary: the device was not returned for evaluation.Images were not provided.Medical records were provided and reviewed.On an unspecified date, ct scan revealed that hook of the filter was at l2-l3 interspace.Also, it was observed that ivc filter was severely tilted with the hook contacting the ivc wall.All the struts were perforating the ivc wall, among which three of the anterior struts perforated the ivc wall and contacting the bowel.Later, the patient presented with gi bleeding.Ct scan revealed that the ivc filter is tilted with multiple struts protruding through the ivc wall and into the duodenum.Following month, patient went surgery for exploratory laparotomy and open retrieval of the ivc filter.The ivc filter was clamped proximally and distally to the ivc filter and an incision at the ivc filter apex was made, grasped with heiss clamp and was pulled.Three months followed by, patient had a septic shock caused by multidrug resistant pseudomonas bacteremia, suspected secondary to the open ventral abdominal wall wound with enterocutaneous fistula.Treatment with merrem was initiated; the patient developed a new left, frontoparietal subarachnoid hemorrhage.Some days later, patient¿s condition declined further and expired.Therefore, the investigation is confirmed for filter tilt, filter limb perforation and unintended movement.Based on the available information, the definitive root cause is unknown.Labeling review: a review of product labeling documents (e.G.Procedural instructions, indications, warnings, precautions, cautions, possible complications, contraindications, and unit label) showed that the product labeling is adequate.(expiry date: 05/2012).
 
Event Description
It was reported through the litigation process that some time post vena cava filter deployment (date not provided) the patient expired.There was no specific device malfunction reported that may or may not have caused or contributed to the patient¿s death.The cause of the patient¿s death was not provided.No other pertinent patient, device or medical information was provided leading up to or surrounding the event.New information: it was reported through the litigation process that a vena cava filter was placed in a patient after being diagnosed with deep vein thrombosis/pulmonary embolism.At some time post filter deployment, it was alleged that the filter tilted laterally with hook contacting ivc wall and struts perforated ivc wall.The device was removed via an open abdominal procedure and the patient subsequently expired.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
G2 FILTER SYSTEM - FEMORAL
Type of Device
VENA CAVA FILTER
Manufacturer (Section D)
BARD PERIPHERAL VASCULAR, INC.
1625 w 3rd st.
tempe AZ 85281
Manufacturer (Section G)
C.R. BARD, INC. (GFO)
289 bay road
queensbury NY 12804
Manufacturer Contact
judith ludwig
1415 w. 3rd street
tempe, AZ 85281
4803032689
MDR Report Key9174352
MDR Text Key161792668
Report Number2020394-2019-03835
Device Sequence Number1
Product Code DTK
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K062887
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type consumer,health professional
Reporter Occupation Non-Healthcare Professional
Type of Report Initial
Report Date 10/10/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received10/10/2019
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue NumberRF310F
Device Lot NumberGFTB3627
Was Device Available for Evaluation? No
Date Manufacturer Received09/20/2019
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
ALBUTEROL, SEVELAMER, INSULIN, BACITRACIN; CHLORASEPTIC, CINACALCET, CORDARONE; GLUCAGON, IMODIUM, MENTHOL-ZINC OXIDE; NYSTATIN, PROAMATINE, PROCRIT, PROTONIX; RISAMINE, SIMETHICONE, ALBUTEROL; WARFARIN, SENSIPAR, NEPHRO, GABAPENTIN
Patient Outcome(s) Death; Hospitalization; Required Intervention;
-
-